Biotechnology GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years – GSK (NYSE:GSK) Read more
Biotechnology Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans – Moderna (NASDAQ:MRNA) Read more
Biotechnology Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck’s Pneumococcal Shots – Analyst Says – Vaxcyte (NASDAQ:PCVX) Read more
Biotechnology Chinese Biotech YS Biopharma’s Next-Gen Rabies Vaccine Non-Inferior To Approved Competitor – YS Biopharma Co (NASDAQ:YS) Read more
Biotechnology Pfizer Seeks Expanded Use Of Abrysvo As Vaccine Shows Potential In 18+ Patients – Pfizer (NYSE:PFE) Read more
Biotechnology Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Is Chart About To Form A Golden Cross? – Moderna (NASDAQ:MRNA) Read more
Biotechnology CureVac, GSK Partner Release Data On Influenza Vaccine Study – CureVac (NASDAQ:CVAC), GSK (NYSE:GSK) Read more
Biotechnology Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts – Moderna (NASDAQ:MRNA) Read more
Biotechnology Merck Highlights Data From Multiple Phase 3 Trials For Its Investigational Pneumococcal Conjugate Vaccine – Merck & Co (NYSE:MRK) Read more
Biotechnology Pfizer’s Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds – Pfizer (NYSE:PFE) Read more